Clark Allphin
36Patents
27h-index
17Co-inventors
82Inventor score
Filing activity: Sep 12, 1991 → Apr 23, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8778398B2 | Immediate release formulations and dosage forms of gamma-hydroxybutyrate | Human Necessities | 87 | Active |
| US8591922B1 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Human Necessities | 82 | Active |
| US8901173B2 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Human Necessities | 71 | Active |
| US9132107B2 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Human Necessities | 68 | Active |
| US9555017B2 | Methods of making a mixture of salts of gamma-hydroxybutyrate | Human Necessities | 63 | Active |
| US8771735B2 | Immediate release dosage forms of sodium oxybate | Human Necessities | 59 | Active |
| US10398662B1 | GHB formulation and method for its manufacture | Human Necessities | 58 | Active |
| US9795567B2 | Immediate release formulations and dosage forms of gamma-hydroxybutyrate | Human Necessities | 54 | Active |
| US10195168B2 | Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders | Human Necessities | 53 | Active |
| US10813885B1 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 50 | Active |
| US10758488B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 49 | Active |
| US9801852B2 | Devices and methods for facilitating and controlling use of a medication | Human Necessities | 48 | Active |
| US10959956B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 47 | Active |
| US10966931B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 47 | Active |
| US11077079B1 | GHB formulation and method for its manufacture | Human Necessities | 45 | Active |
| US11090269B1 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 45 | Active |
| US10987310B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 44 | Active |
| US11147782B1 | GHB formulation and method for its manufacture | Human Necessities | 41 | Active |
| US11207270B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 40 | Active |
| US10675258B2 | Method of using gamma-hydroxybutyrate compositions for the treatment of disorders | Human Necessities | 38 | Active |
| US8609651B2 | Pharmaceutical compositions of benzodiazepines and method of use thereof | Human Necessities | 36 | Active |
| US11033530B2 | Devices and methods for facilitating and controlling use of a medication | Human Necessities | 35 | Active |
| US10195151B2 | Formulations of (R)-2-amino-3-phenylpropyl carbamate | Human Necessities | 35 | Active |
| US11400052B2 | Alcohol-resistant drug formulations | Human Necessities | 34 | Active |
| US10512609B2 | Formulations of (R)-2-amino-3-phenylpropyl carbamate | Human Necessities | 34 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.